Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cadherin-1 (CDH1), also known as E-cadherin, is a calcium-dependent cell-cell adhesion glycoprotein primarily expressed in epithelial tissues. It is essential for maintaining proper cell-cell adhesion, tissue architecture, and cellular polarity. E-cadherin acts as a tumor suppressor, and its loss or mutation promotes cancer metastasis. It mediates homophilic interactions, crucial for epithelial integrity and suppressing invasion/metastasis. Interactions with catenins like p120 are essential for cell junction stability and signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cadherin-1 (CDH1).